Please sign in to follow a disease.
Neushen Therapeutics
Clinical trials sponsored by Neushen Therapeutics, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New schizophrenia drug shows promise in early trial Results expected Nov 2026 (estimated)
- New drug NS-079 tested in healthy people for first time Results expected Feb 2027 (estimated)